Profil
Rupert Haynes is the founder of Avata Biosciences.
Former jobs include Chief Executive Officer at Quantum BioPharma Ltd. from 2018 to 2019, Director-Global Marketing at GW Pharmaceuticals Ltd., Head-Global Commercial Operations at Swedish Orphan Biovitrum AB, and Head-Global Strategy at Radius Health, Inc. from 2021 to 2023.
Postes actifs de Rupert Haynes
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Rupert Haynes
| Sociétés | Poste | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01/10/2023 |
| QUANTUM BIOPHARMA LTD. | Directeur Général | 06/02/2019 |
| GW PHARMACEUTICALS PLC | Sales & Marketing | - |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
FSD Pharma, Inc.
FSD Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurodegenerative, inflammatory and metabolic disorders | Health Technology |
















